CODING: Words stricken are deletions; words underlined are additions.
c2943534
Senate
s0300-98
s0370
2002
AA
104940
Senator Saunders moved the following amendment to amendment
(104940):
On page 97, between lines 23 and 24,
On page 107, line 21, after the semicolon




                                                  SENATE AMENDMENT

    Bill No. CS for CS for SB 370

    Amendment No. ___   Barcode 943534

                            CHAMBER ACTION
              Senate                               House
                                   .
                                   .
  1                                .
                                   .
  2                                .
                                   .
  3                                .
                                   .
  4  ______________________________________________________________

  5

  6

  7

  8

  9

10  ______________________________________________________________

11  Senator Saunders moved the following amendment to amendment

12  (104940):

13

14         Senate Amendment (with title amendment) 

15         On page 97, between lines 23 and 24,

16

17  insert:

18         Section 80.  Subsection (2) of section 499.007, Florida

19  Statutes, is amended to read:

20         499.007  Misbranded drug or device.--A drug or device

21  is misbranded:

22         (2)  Unless, if in package form, it bears a label

23  containing:

24         (a)  The name and place of business of the manufacturer

25  or distributor; in addition, for a medicinal drug, as defined

26  in s. 499.003, the label must contain the name and place of

27  business of the manufacturer of the finished dosage form of

28  the drug.  For the purpose of this paragraph, the finished

29  dosage form of a medicinal drug is that form of the drug which

30  is, or is intended to be, dispensed or administered to the

31  patient and requires no further manufacturing or processing

                                  1
    2:14 PM   03/19/02                              s0370c2c-25ry5




                                                  SENATE AMENDMENT

    Bill No. CS for CS for SB 370

    Amendment No. ___   Barcode 943534





  1  other than packaging, reconstitution, and labeling; and

  2         (b)  An accurate statement of the quantity of the

  3  contents in terms of weight, measure, or numerical count;

  4  however, under this section, reasonable variations are

  5  permitted, and the department shall establish by rule

  6  exemptions for small packages.

  7

  8  A drug dispensed by filling or refilling a written or oral

  9  prescription of a practitioner licensed by law to prescribe

10  such drug is exempt from the requirements of this section,

11  except subsections (1), (8), (10), and (11) and the packaging

12  requirements of subsections (6) and (7), if the drug bears a

13  label that contains the name and address of the dispenser or

14  seller, the prescription number and the date the prescription

15  was written or filled, the name of the prescriber and the name

16  of the patient, and the directions for use and cautionary

17  statements.  This exemption does not apply to any drug

18  dispensed in the course of the conduct of a business of

19  dispensing drugs pursuant to diagnosis by mail or to any drug

20  dispensed in violation of subsection (12).  The department

21  may, by rule, exempt drugs subject to ss. 499.062-499.064 from

22  subsection (12) if compliance with that subsection is not

23  necessary to protect the public health, safety, and welfare.

24

25  (Redesignate subsequent sections.)

26

27

28  ================ T I T L E   A M E N D M E N T ===============

29  And the title is amended as follows:

30         On page 107, line 21, after the semicolon

31

                                  2
    2:14 PM   03/19/02                              s0370c2c-25ry5




                                                  SENATE AMENDMENT

    Bill No. CS for CS for SB 370

    Amendment No. ___   Barcode 943534





  1  insert:

  2         amending s. 499.007, F.S.; redefining

  3         circumstances that cause a drug or device to be

  4         considered misbranded;

  5

  6

  7

  8

  9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

                                  3
    2:14 PM   03/19/02                              s0370c2c-25ry5